Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Tu

Showing results (411-420 of 476) with videos related to

Pageof 48
Sort By:
Surgical Oncology|March 19, 2018
Preoperative lymph node size is helpful to predict the prognosis of patients with stage III gastric cancer after radical resectionXin-Chang Shang-Guan, Qi-Yue Chen, Ping Li, et al.
JAMA Surgery|February 27, 2020
Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical TrialQi-Yue Chen, Jian-Wei Xie, Qing Zhong, et al.
Surgical Endoscopy|June 4, 2021
Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matchingZe-Ning Huang, YuBin Ma, Qi-Yue Chen, et al.
Cell Death & Disease|July 12, 2024
Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathwayMi Lin, Ru-Hong Tu, Sheng-Ze Wu, et al.
Medicine|January 18, 2019
What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?Jun Lu, Yun Dai, Hua-Long Zheng, et al.
BMC Cancer|November 8, 2019
Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter dataJian-Xian Lin, Zu-Kai Wang, Wei Wang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 11, 2019
The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial dataBin-Bin Xu, Jun Lu, Zhi-Fang Zheng, et al.
Frontiers in Oncology|August 13, 2021
Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric CancerJian-Wei Xie, Jun Lu, Bin-Bin Xu, et al.
Annals of Surgery|September 5, 2020
Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled TrialJun Lu, Chao-Hui Zheng, Bin-Bin Xu, et al.
Surgical Endoscopy|June 23, 2018
Comparison of short-term and long-term efficacy of laparoscopic and open gastrectomy in high-risk patients with gastric cancer: a propensity score-matching analysisBin-Bin Xu, Jun Lu, Zhi-Fang Zheng, et al.
Pageof 48

Showing results (411-420 of 476) with videos related to

Sort By:
Pageof 48
Surgical Oncology|March 19, 2018
Preoperative lymph node size is helpful to predict the prognosis of patients with stage III gastric cancer after radical resectionXin-Chang Shang-Guan, Qi-Yue Chen, Ping Li, et al.
JAMA Surgery|February 27, 2020
Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical TrialQi-Yue Chen, Jian-Wei Xie, Qing Zhong, et al.
Surgical Endoscopy|June 4, 2021
Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matchingZe-Ning Huang, YuBin Ma, Qi-Yue Chen, et al.
Cell Death & Disease|July 12, 2024
Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathwayMi Lin, Ru-Hong Tu, Sheng-Ze Wu, et al.
Medicine|January 18, 2019
What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?Jun Lu, Yun Dai, Hua-Long Zheng, et al.
BMC Cancer|November 8, 2019
Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter dataJian-Xian Lin, Zu-Kai Wang, Wei Wang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 11, 2019
The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial dataBin-Bin Xu, Jun Lu, Zhi-Fang Zheng, et al.
Frontiers in Oncology|August 13, 2021
Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric CancerJian-Wei Xie, Jun Lu, Bin-Bin Xu, et al.
Annals of Surgery|September 5, 2020
Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled TrialJun Lu, Chao-Hui Zheng, Bin-Bin Xu, et al.
Surgical Endoscopy|June 23, 2018
Comparison of short-term and long-term efficacy of laparoscopic and open gastrectomy in high-risk patients with gastric cancer: a propensity score-matching analysisBin-Bin Xu, Jun Lu, Zhi-Fang Zheng, et al.
Pageof 48